ã?? Wondfo Biotech Co., Ltd (Wondfo) was founded in 1992 as a research based company on the campus of South China University of Technology in Guangzhou, Guangdong Province. The operation quickly grew beyond research purposes towards custom manufacturing of quality medical products and biochemical reagents. With strong support from the government and local university, Wondfo has obtained ISO 9001 certificate, GMP approval, FDA approval and CE Mark already. Currently Wondfo employs over 100 employees housed in state of the art facilities encompassing over 14, 000 square feet of laboratory space. Based on the technical resources from South China University of Technology over 30% of the employed staff have obtained master and doctor degree from prestigious worldwide institutions. By consistently investing resources in staff training and technological development, Wondfo is constantly building a superb team of professionals in quality control, production, management, and international distribution operations. Wondfo has pioneered new and advanced engineering techniques in immunological manufacturing by combining artistry of the development team with technological application of automated manufacturing equipment. In order to assure the product of best quality and stability, Wondfo established the aseptic workshop (according to the GMP standards), in addition to temperature and humidity controlled lab environment. Wondfo also houses a technical team that has developed customized Immunogold Labeling Techniques with automated procedures for water purgation, cell cultivation, purity analysis, packaging & sorting, and testing. Wondfo pays strict attention to quality control processes while utilizing cost cutting application of automated equipment, resulting in superb quality products with very affordable prices. Wondfo also focuses on excellent client-centered support with experienced sales and marketing team that is fluent in both Chinese and English, in addition to strong international import - export experience. The future plans include product diversification with strong marketing expansion into North and South America, Europe, Middle East, and other demanding markets. Wondfo is currently developing plans to obtain certificates for both US FDA and European CE Mark registrations for all the products, in order to fulfill distributor needs in those regions. "Excellent QUALITY, PRICING, and SERVICE are three basic principles that make Wondfo a leader in the biomedical enterprise of the future."